Novavax (NVAX) Stock Up 8% Yesterday as FDA Approves Updated Covid Vaccine but Is 6% Down Now Submitted by Anonymous (not verified) on Wed, 10/04/2023 - 18:10 Coinspeaker
Moderna (MRNA) Shares Drop 8% despite Impressive Result from Cancer Vaccine Phase 2 Trial Submitted by Anonymous (not verified) on Tue, 04/18/2023 - 11:20 Coinspeaker
Moderna Gains 7% as Cowen Upgrades MRNA Stock from Market Perform to Outperform Submitted by Anonymous (not verified) on Tue, 03/14/2023 - 11:10 Coinspeaker
Moderna Sees X3 Covid Vaccine Sales in Q1 2022, MRNA Stock Jumps 7% Submitted by Anonymous (not verified) on Wed, 05/04/2022 - 18:00 Coinspeaker
Roche Q1 2022 Results Beat Expectations, Company Confirms 2022 Outlook Submitted by Anonymous (not verified) on Mon, 04/25/2022 - 16:10 Coinspeaker
US Stock Market Records Bullish Resurgence as Investors Weigh in on Fed’s Policy Submitted by Anonymous (not verified) on Fri, 04/08/2022 - 13:10 Coinspeaker
China Sees Worst Covid Outbreak Yet, Vaccine Makers Stocks Surge Submitted by Anonymous (not verified) on Tue, 03/15/2022 - 13:20 Coinspeaker
MRNA Shares Up 9% as Moderna Starts Working on Booster Targeting Omicron Variant Submitted by Anonymous (not verified) on Tue, 01/11/2022 - 11:30 Coinspeaker
PFE Stock Slightly Up, Pfizer CEO Says Omicron Vaccine to Be Ready in March Submitted by Anonymous (not verified) on Tue, 01/11/2022 - 11:30 Coinspeaker
European Stock Market Edges Higher despite Persistent Omicron Fears Submitted by Anonymous (not verified) on Mon, 12/27/2021 - 15:20 Coinspeaker